American Well Corp. (AMWL)
4.77
+0.05
(+1.06%)
USD |
NYSE |
Jan 14, 11:01
American Well Research and Development Expense (Quarterly): 18.58M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Doximity, Inc. | 30.20M |
| Spok Holdings, Inc. | 2.993M |
| DarioHealth Corp. | 3.328M |
| National Research Corp. | -- |
| GoodRx Holdings, Inc. | 31.01M |